Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 1,177,596 |
|
|||||
| News | - | ||||||
| Day High | 1.43 | Low High |
|||||
| Day Low | 1.33 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Atossa Therapeutics Inc | ATOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0699 | -4.92% | 1.3501 | 17:03:20 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.43 | 1.33 | 1.43 | 1.37 | 1.42 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,083 | 1,177,596 | $ 1.37 | $ 1,615,884 | - | 0.5901 - 2.31 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:03:20 | formt | 800 | $ 1.3501 | USD |
Atossa Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 171.67M | 125.30M | - | 0 | -26.96M | -0.22 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Atossa Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.83 | 1.83 | 1.24 | 1.49 | 2,348,806 | -0.4799 | -26.22% |
| 1 Month | 1.70 | 2.31 | 1.24 | 1.79 | 3,132,050 | -0.3499 | -20.58% |
| 3 Months | 0.83 | 2.31 | 0.80 | 1.59 | 1,700,649 | 0.5201 | 62.66% |
| 6 Months | 0.665 | 2.31 | 0.62 | 1.43 | 991,061 | 0.6851 | 103.02% |
| 1 Year | 0.76 | 2.31 | 0.5901 | 1.25 | 834,847 | 0.5901 | 77.64% |
| 3 Years | 1.63 | 9.80 | 0.50 | 3.75 | 3,328,235 | -0.2799 | -17.17% |
| 5 Years | 2.54 | 9.80 | 0.50 | 3.21 | 3,492,908 | -1.19 | -46.85% |
Atossa Therapeutics Description
| Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. |
